[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 271
Citations 0
Correction
December 12, 2018

Rewording in Discussion for Clarification

JAMA Surg. 2019;154(3):272. doi:10.1001/jamasurg.2018.4925

In the article titled “Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer,”1 the wording regarding guidelines referred to in the Discussion has been revised for accuracy. The guidelines referred to had not been published at the time of the study,1 so the sentence, “Guidelines published after this study was conducted recommend pretest genetic counseling and acknowledge that the complexities in interpretation of modern panel testing require that providers (eg, laboratories, oncology physicians, and counselors) with particular expertise in cancer risk assessment be involved in their ordering and interpretation,” was added for clarification. The article was corrected online.

References
1.
Katz  SJ, Bondarenko  I, Ward  KC,  et al.  Association of attending surgeon with variation in the receipt of genetic testing after diagnosis of breast cancer.  JAMA Surg. 2018;153(10):909-916. doi:10.1001/jamasurg.2018.2001PubMedGoogle ScholarCrossref
×